THBD and COVID-19: The release of vWF, selectins, and ICAM-1 following EC activation binds platelets, neutrophils, and monocytes to initiate thrombosis, while the shedding of thrombomodulin by pro-inflammatory cytokines would further promote the procoagulant and inflammatory milieu within the vasculature of COVID-19 patients [98].